Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs

P. Ewing, A. Blomgren, S. Eirefelt, P. Andersson, A. Ryrfelt, P. Gerde (Stockholm, Lund, Sweden)

Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Session: Evaluation of drugs for lung disease
Session type: Thematic Poster Session
Number: 1255
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Ewing, A. Blomgren, S. Eirefelt, P. Andersson, A. Ryrfelt, P. Gerde (Stockholm, Lund, Sweden). Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs. Eur Respir J 2006; 28: Suppl. 50, 1255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficient deposition and absorption of orally inhaled indacaterol in the lungs
Source: Annual Congress 2011 - COPD management
Year: 2011


No evidence electric charge increases inhaled ultrafine particle deposition in human lungs
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020


A human lung reperfusion model for monitoring the initial pulmonary absorption of drugs from aerosol devices
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005

Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Determination of tissue concentrations of metabolites in surgical preparations following inhalation of beclomethasone-dipropionate using conventional and extrafine aerosols
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

Efficient deposition and sustained lung concentrations of NVA237 after inhalation via the Breezhaler® device in man
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Pressure supported nasal inhalation improving penetration of particles into the human lung
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012

Fast clearance of inhaled ultrafine particles from airways is reduced in a knockout mouse model with cilia deficiency
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007


Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Throat deposition of inhaled drug can explain the variability in lung deposition
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005

Improvement of small airway deposition of corticosteroids by smart nebulisation
Source: International Congress 2018 – Asthma and drugs
Year: 2018


Greater esterification and retention of budesonide in the airways and lung as compared to ciclesonide after repeated intratracheal administration in vivo
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004

Functional respiratory imaging assessment of the aerosol deposition of inhaled levofloxacin in cystic fibrosis lungs
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021


A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Gamma-scintigraphic evaluation of the delivered dose, lung deposition rate and distribution pattern of 99mTc-labelled tiotropium via dry powder inhaler
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

Single-breath, real time measurement of lung deposition of tobacco smoke fine particles: the correlation between particle burden and regional particle deposition fraction
Source: Annual Congress 2007 - The versatile aspects of nicotine addiction
Year: 2007


Regional distribution of inhaled particles measured with isotope scanning or modelled with computational fluid dynamics
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006


Lung deposition of an aerosol produced by a new inhalation device for ventilated patients
Source: Eur Respir J 2005; 26: Suppl. 49, 88s
Year: 2005